Parkinson's Disease, adaptive DBS and FDA

FDA Approves Adaptive Deep Brain Stimulator for Parkinson's Disease
The FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode identifier) for people with Parkinson's disease, Medtronic announced Monday. Like other DBS devices,
US FDA approves Medtronic's medical device for Parkinson's disease
The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with Parkinson's disease, the medical device maker said on Monday.
FDA OKs First Adaptive DBS System for Parkinson’s Disease
The closed-loop system dynamically self-adjusts DBS therapy to individual brain activity in real time, providing personalized neuromodulation that responds to the patient’s changing needs.
Medtronic Parkinson's Disease Brain Stimulation System Gets FDA Approval
Medtronic said the Food and Drug Administration approved a brain stimulation system for people afflicted with Parkinson's disease.
FDA approves Medtronic’s adaptive technology for Parkinson’s
The company's adaptive deep brain stimulation technology for Parkinson's disease therapy is expected to be available nationwide in the next few months.
FDA Approves Medtronic’s BrainSense Adaptive Deep Brain Stimulation for Parkinson Disease
The BrainSense adaptive deep brain stimulation system personalizes therapy by dynamically adjusting stimulation based on real-time brain activity to improve Parkinson disease symptom control without manual adjustments.
In Parkinson’s fight, Medtronic’s first-in-the-world adaptive therapy feature wins FDA approval
After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive technology personalizing treatment of Parkinson’s symptoms using advanced stimulation deep in the brain.
Medtronic's deep brain stimulation system for Parkinson's disease wins FDA nod
Medtronic (NYSE:MDT) has won FDA approval for a deep brain stimulation system for Parkinson’s disease. The approval is for BrainSense Adaptive deep brain stimulation (DBS)and BrainSense Electrode Identifier.
Parkinson’s Patients Have a New Way to Manage Their Symptoms
T here is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
Studies of Parkinson’s disease have long overlooked Pacific populations – our work shows why that must change
A form of Parkinson’s disease caused by mutations in a gene known as PINK1 has long been labelled rare. But our research ...
News Medical on MSN5h
FDA-approved technology offers personalized treatment for Parkinson’s symptoms
Starting today, people with Parkinson's disease will have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology.
Jake Paul causes Mike Tyson Parkinson’s disease stir in wild interview after controversial fight
The Tyson-Paul fight had to be re-scheduled from July 20 to Nov. 15 after Tyson had a medical emergency on a plane during the ...
Mike Tyson Sets Record Straight On Parkinson’s Disease Rumors
Mike Tyson is setting the record straight amid rumors he has Parkinson's Disease following comments made by Jake Paul.   The ...
News Medical on MSN6d
Cholesterol metabolite linked to Parkinson's disease development in mice
Researchers led by Zhentao Zhang at Wuhan University, China have discovered a cholesterol metabolite that plays a critical ...
Parkinson's centre a one-stop-shop of support for those with the neurological disease
Parkinson Wellness Projects’ 5,000-square-foot centre at Blanshard and Hillside offers everything from exercise programs to ...
The Spun on MSN16h
Former NFL Quarterback Dead From Parkinson's at 74
A former NFL quarterback has passed away at 74 years old, following a battle with Parkinson's disease and prostate cancer.